◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksA › ADUS

Addus HomeCare Corporation (ADUS) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL CARE FACILITIES · DATA UPDATED 2026-09-06

Addus HomeCare Corporation (ADUS) operates in the MEDICAL CARE FACILITIES industry and is headquartered in Frisco, United States with about 5,982 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, ADUS reported $1.4B in revenue and $96M in net income.

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States.

Interactive charts & full statements → Open the ADUS valuation workbench →

ADUS Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Total Revenue$1.5B$1.4B$1.2B$1.1B$951M$864M$765M$649M$518M$426M$401M$337M$313M$266M$244M$273M$272M$259M$236M$195M
Gross Profit$478M$462M$375M$340M$300M$270M$226M$179M$138M$116M$106M$91M$84M$68M$64M$82M$80M$77M$69M$55M
Gross Margin %32.4%32.5%32.5%32.1%31.5%31.2%29.6%27.6%26.7%27.2%26.5%27.1%26.8%25.5%26.2%29.9%29.4%29.5%29.2%28.4%
Operating Income (EBIT)$148M$139M$103M$91M$69M$66M$45M$35M$23M$25M$15M$16M$18M$15M$15M($4M)$12M$12M$11M$5M
Operating Margin %10.0%9.7%8.9%8.6%7.2%7.6%5.8%5.4%4.4%5.9%3.9%4.8%5.8%5.8%6.2%-1.5%4.4%4.5%4.6%2.6%
Net Income$105M$96M$74M$63M$46M$45M$33M$25M$18M$14M$12M$12M$12M$19M$8M($2M)$6M$4M$4M$0M
Net Margin %7.1%6.7%6.4%5.9%4.8%5.2%4.3%3.9%3.4%3.2%3.0%3.5%3.9%7.2%3.1%-0.7%2.2%1.4%1.7%0.1%
EBITDA$167M$153M$121M$107M$83M$81M$57M$45M$34M$33M$25M$21M$22M$18M$18M$2M$16M$17M$17M$11M
Earnings Per Share (EPS)$5.71$5.20$4.23$3.83$2.84$2.81$2.08$1.62$1.33$1.17$1.04$1.04$1.10$1.73$0.71$-0.18$0.57$1.33$3.95$0.19
Shares Outstanding (M)18M18M17M16M16M16M16M16M13M12M12M11M11M11M11M11M11M3M1M1M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ADUS Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Revenue$377M$364M$373M$362M$349M$338M$297M$290M
Gross Profit$122M$116M$124M$117M$114M$108M$101M$92M
Gross Margin %32.2%31.9%33.1%32.2%32.6%31.9%34.2%31.8%
Operating Income (EBIT)$39M$34M$42M$33M$33M$31M$27M$26M
Operating Margin %10.3%9.4%11.3%9.1%9.4%9.0%9.1%9.0%
Net Income$28M$25M$30M$23M$22M$21M$20M$20M
Net Margin %7.3%6.9%8.0%6.3%6.3%6.3%6.6%7.0%
EBITDA$44M$39M$47M$38M$37M$35M$32M$31M
Earnings Per Share (EPS)$1.49$1.36$1.61$1.24$1.20$1.15$1.07$1.10
Shares Outstanding (M)18M18M18M18M18M18M18M18M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ADUS Free Cash Flow History

Cash flowTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Cash from Operations (CFO)$162M$112M$116M$112M$105M$39M$109M$12M$33M$53M($1M)$4M$7M$27M$15M$16M$11M($9M)$5M$3M
Capital Expenditures (CapEx)$9M$8M$6M$9M$8M$5M$7M$5M$5M$4M$2M$2M$5M$1M$1M$1M$1M$1M$0M$1M
Free Cash Flow (FCF)$153M$104M$110M$103M$97M$35M$103M$7M$28M$49M($2M)$2M$2M$27M$14M$15M$10M($10M)$4M$3M
FCF Margin %10.4%7.3%9.6%9.7%10.2%4.0%13.4%1.1%5.4%11.6%-0.6%0.5%0.5%10.0%5.9%5.6%3.7%-3.7%1.8%1.4%
Dividends Paid$0M$0M$0M$0M$0M$4M$2M$2M$15M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ADUS Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Cash from Operations (CFO)$40M$52M$19M$51M$23M$19M$10M$49M
Capital Expenditures (CapEx)$3M$2M$3M$2M$1M$2M$2M$2M
Free Cash Flow (FCF)$37M$51M$16M$49M$21M$17M$9M$47M
FCF Margin %9.8%13.9%4.3%13.6%6.1%5.1%2.9%16.1%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ADUS Balance Sheet History

Balance sheet2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Total Assets$1.5B$1.4B$1.4B$1.0B$938M$948M$893M$637M$355M$267M$231M$193M$181M$164M$150M$155M$167M$161M$136M$119M
Cash & Cash Equivalents$100M$82M$99M$65M$80M$169M$145M$112M$70M$54M$8M$4M$13M$16M$2M$2M$1M$1M$6M$0M
Total Liabilities$308M$352M$442M$318M$304M$373M$374M$161M$80M$92M$72M$51M$53M$50M$55M$68M$79M$81M$101M$84M
Total Debt (Short + Long-Term)$75M$134M$231M$135M$143M$231M$204M$60M$17M$43M$25M$3M$4M$2M$16M$32M$45M$49M$72M$60M
Total Shareholders' Equity$1.1B$1.1B$970M$707M$634M$574M$519M$476M$276M$176M$159M$142M$128M$114M$94M$86M$88M$81M$35M$35M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ADUS viewer.

Other Companies in MEDICAL CARE FACILITIES

← ADURAll “A” companiesADV →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.